By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Drugs > Leniolisib (monograph) > Leniolisib Dosage
Drugs
https://themeditary.com/dosage-information/leniolisib-dosage-9427.html

Leniolisib Dosage

Drug Detail:Leniolisib (monograph) (Joenja)

Drug Class:

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

Usual Adult Dose for Activated PI3K-Delta Syndrome

Recommended dosage: 70 mg orally twice daily

Comments:

  • Should be taken approximately 12 hours apart, with or without food.
  • Recommended only for patients weighing 45 kg and above.

Use: For the treatment of adults with activated phosphoinositide 3-kinase delta (PI3K-delta) syndrome (APDS)

Usual Pediatric Dose for Activated PI3K-Delta Syndrome

Recommended dosage:

  • 12 years or older weighing 45 kg or greater: 70 mg orally twice daily

Comments:
  • Should be taken approximately 12 hours apart, with or without food.

Use: For the treatment of pediatric patients with activated phosphoinositide 3-kinase delta (PI3K-delta) syndrome (APDS)

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Moderate to severe liver dysfunction: Not recommended.

Precautions

CONTRAINDICATIONS: None

Safety and efficacy have not been established in patients younger than 12 years or less than 45 kg.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:

  • Oral use only. Administer with or without food.
  • If a dose is missed by more than 6 hours, the patient should take the next scheduled dose.
  • If vomiting occurs within 1 hour after administration, advise the patient to take a dose as soon as possible.

Storage requirements:
  • Store at 20C to 25C (68F to 77F); excursions permitted between 15C to 30C (59F to 86F).
  • Do not refrigerate.
  • Store and dispense in the original container.

General:
  • This drug has not been studied in patients 65 years and older.
  • Verify the pregnancy status of females of reproductive potential before initiating treatment and discuss potential risks to a fetus with pregnant patients.

Monitoring:
  • Pregnancy: Prior to initiation and during therapy

Patient advice:
  • Female patients should notify their healthcare provider if they are pregnant or planning to become pregnant while on this drug.
  • Effective contraception is strongly advised during treatment with this drug and for one week after.
  • Breastfeeding is not recommended while on this drug and for one week after the last dose.
Share this Article
Latest News
Medical News

Type 2 diabetes: Sugary drinks may significantly raise risk

May 30, 2025
COVID-19: Who do the new vaccine guideline changes affect?
Vitamin D supplements may help slow down aging by 3 years
Aging: Exercise timing, consistency can affect heart and lung fitness
Heart health: Exercise not enough to offset effects of poor sleep
Ministrokes may result in 1 year of chronic fatigue
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by